Stay updated on Sitravatinib in Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.

Latest updates to the Sitravatinib in Hepatic Impairment Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the term 'Hepatic Impairment', while significant details regarding a clinical study have been removed, including key inclusion and exclusion criteria.SummaryDifference33%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Sitravatinib in Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.